As shown in Supplementary Fig. 7e, HectH9 deficiency did not cause Myc stabilization in prostate and breast cancer cells, reducing the likelihood that the anti-cancer activities by HectH9 targeting in these cancer types would be countered by Myc upregulation. This evidence concerns the gene HUWE1 and breast carcinoma.